PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R37CA215427
NCI NIH HHS
Grant: R01 CA240607
National Institutes of Health
Grant: 5R01CA240607-04
A novel therapy for pancreatic neuroendocrine tumors
National Institutes of Health
Grant: 5R37CA215427-04
Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Additional file 1 of DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Additional file 2 of DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming
Additional file 2 of DNMT3A mutation promotes leukemia development through NAM-NAD metabolic reprogramming